StockData
Kazia Therapeutics Ltd logo

Kazia Therapeutics Ltd (KZIA) stock

KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2026Score 1/30
$5.49+0.18 (+3.39%)

Close on Nov 18, 2026Market cap $8.89MP/E –Yield –

Kazia Therapeutics cash

Cash and short-term investments held at the end of each period.

Kazia Therapeutics's cash was A$69.46M at Dec 31, 2025. For fiscal 2025 it was A$4.34M, up 162.1% from the year before. Over ten years it grew -20.7% a year on average. The highest annual figure on record is A$44.37M in fiscal 2015.

Annual cash

PeriodPeriod endValueChange
FY2025Jun 30, 2025A$4.34M+162.1%
FY2024Jun 30, 2024A$1.66M-68.4%
FY2023Jun 30, 2023A$5.24M-28.8%
FY2022Jun 30, 2022A$7.36M-73.3%
FY2021Jun 30, 2021A$27.59M+214.8%
FY2020Jun 30, 2020A$8.76M+61.3%
FY2019Jun 30, 2019A$5.43M-8.8%
FY2018Jun 30, 2018A$5.96M-58.8%
FY2017Jun 30, 2017A$14.46M-56.8%
FY2016Jun 30, 2016A$33.45M-24.6%
FY2015Jun 30, 2015A$44.37M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ4 2025Dec 31, 2025A$69.46M+1849.7%
Q4 FY2025CQ2 2025Jun 30, 2025A$4.34M-17.1%
Q2 FY2025CQ4 2024Dec 31, 2024A$3.06M-30.2%
Q4 FY2024CQ2 2024Jun 30, 2024A$1.66M-77.5%
Q2 FY2024CQ4 2023Dec 31, 2023A$3.56M-76.5%
Q4 FY2023CQ2 2023Jun 30, 2023A$5.24M-81.0%
Q2 FY2023CQ4 2022Dec 31, 2022A$4.39M-49.9%
Q4 FY2022CQ2 2022Jun 30, 2022A$7.36M+35.5%
Q2 FY2022CQ4 2021Dec 31, 2021A$15.19M+155.0%
Q4 FY2021CQ2 2021Jun 30, 2021A$27.59M+90.8%
Q4 FY2020CQ2 2020Jun 30, 2020A$8.76M-73.8%
Q4 FY2019CQ2 2019Jun 30, 2019A$5.43M-87.8%
Q4 FY2018CQ2 2018Jun 30, 2018A$5.96M–
Q4 FY2017CQ2 2017Jun 30, 2017A$14.46M–
Q4 FY2016CQ2 2016Jun 30, 2016A$33.45M–
Q4 FY2015CQ2 2015Jun 30, 2015A$44.37M–

More Kazia Therapeutics figures

See a number that looks wrong?